Top Page
Synthomer
(LSE:SYNT)
Synthomer (SYNT) vs. S&P 500 (SPY)
Synthomer Business Overview & Revenue Model
Synthomer Financial Statement Overview
| Breakdown | ||||
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 1.97B | 2.38B | 2.14B | 1.64B | 1.46B | Gross Profit |
| 307.30M | 281.00M | 569.70M | 336.70M | 213.00M | EBIT |
| -35.40M | 114.30M | 400.80M | 156.50M | 117.40M | EBITDA |
| 117.90M | 139.40M | 394.40M | 146.90M | 168.20M | Net Income Common Stockholders |
| -67.00M | -32.50M | 208.70M | 3.10M | 84.60M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 371.30M | 227.70M | 505.30M | 201.80M | 103.60M | Total Assets |
| 2.71B | 3.15B | 2.55B | 2.13B | 1.26B | Total Debt |
| 926.30M | 1.30B | 663.00M | 719.00M | 124.80M | Net Debt |
| 555.00M | 1.07B | 157.70M | 517.20M | 21.20M | Total Liabilities |
| 1.54B | 2.11B | 1.52B | 1.50B | 588.90M | Stockholders Equity |
| 1.15B | 1.02B | 1.02B | 615.00M | 649.40M |
| Cash Flow | Free Cash Flow | |||
| 66.00M | 45.00M | 193.20M | 134.90M | 84.40M | Operating Cash Flow |
| 150.00M | 135.80M | 275.40M | 188.70M | 153.50M | Investing Cash Flow |
| 107.70M | -850.10M | -80.50M | -367.70M | -68.80M | Financing Cash Flow |
| -90.90M | 414.50M | 118.50M | 273.20M | -60.00M |
Synthomer Technical Analysis
Synthomer Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | £4.12B | 25.99 | 6.84% | 3.69% | -3.92% | -7.30% | |
64 Neutral | £864.68M | 45.30 | 2.74% | 4.81% | -5.66% | -76.42% | |
63 Neutral | £742.78M | 43.17 | 3.58% | 7.17% | -5.21% | -72.13% | |
54 Neutral | £112.40M | ― | -16.93% | ― | 132.44% | 47.77% | |
49 Neutral | $1.93B | -1.47 | -21.02% | 3.74% | 0.80% | -29.57% | |
45 Neutral | £134.61M | ― | -6.25% | ― | 0.81% | 15.63% |
Synthomer Corporate Events
Synthomer plc reported a strong first quarter in 2025, with increased EBITDA and margins compared to the previous year, driven by self-help initiatives and strategic transformation. Despite challenges in the USA and energy solutions markets, the company achieved revenue growth in its Adhesive Solutions and Health & Protection and Performance Materials divisions. Synthomer’s ‘in region for region’ manufacturing strategy has helped mitigate the impact of tariffs, and new investments in the USA and Middle East are contributing positively to profits and cash flow. The company remains focused on cost-efficiency and cash generation, with expectations of further earnings progress in 2025 despite geopolitical uncertainties.
Spark’s Take on GB:SYNT Stock
According to Spark, TipRanks’ AI Analyst, GB:SYNT is a Neutral.
Synthomer’s overall stock score is low, primarily due to challenging financial performance and negative technical indicators. The company’s financial struggles, particularly around profitability and cash flow, weigh heavily on the score. Although recent corporate actions suggest management confidence, these are overshadowed by broader financial and market challenges. The stock’s valuation is also unattractive, reflecting the company’s current difficulties.
To see Spark’s full report on GB:SYNT stock, click here.
Synthomer PLC, a UK-based company, has announced a change in its major holdings with Janus Henderson Group PLC reducing its voting rights from 5.038376% to 4.918311%. This adjustment in holdings, effective as of April 10, 2025, reflects a minor shift in the company’s shareholder structure, potentially impacting its governance and decision-making processes.
Spark’s Take on GB:SYNT Stock
According to Spark, TipRanks’ AI Analyst, GB:SYNT is a Neutral.
Synthomer’s stock is challenged by financial and technical weaknesses, with a negative P/E ratio and lack of dividend yield further impacting valuation. However, the positive corporate events suggest management’s confidence in future prospects, providing a partial counterbalance. Overall, the stock’s score reflects significant room for improvement in financial health and market performance.
To see Spark’s full report on GB:SYNT stock, click here.
Synthomer plc announced the deferral of part of its 2024 annual cash bonus for CEO Michael Willome into shares, marking the final tranche of this transaction. This move, involving 47,000 shares at a price of £1.20582 each, reflects the company’s strategic approach to align executive compensation with shareholder interests, potentially impacting its financial management and market perception.
Synthomer PLC announced that its Chair, Peter Hill, has purchased 50,000 ordinary shares of the company at a price of £1.16 per share, totaling £58,000. This transaction, conducted on the London Stock Exchange, signifies confidence in the company’s future prospects and may positively influence stakeholder perceptions.
Synthomer plc announced that its Chief Financial Officer, Lily Liu, has been granted nil cost options under the Synthomer Performance Share Plan, subject to performance conditions. This transaction, involving 826,418 ordinary shares, reflects the company’s commitment to aligning executive incentives with performance, potentially impacting stakeholder confidence and the company’s strategic objectives.
Synthomer plc has published its 2024 annual report and accounts, along with the notice for the 2025 annual general meeting, which will be held on May 1, 2025. These documents have been submitted to the Financial Conduct Authority and are available for inspection through the National Storage Mechanism and the company’s website, reflecting compliance with regulatory requirements and ensuring transparency for stakeholders.
Synthomer PLC has announced a change in its major holdings, with Artemis Investment Management LLP now holding 5.436171% of voting rights, up from a previous 5.034027%. This shift in voting rights indicates a strategic move by Artemis, potentially impacting Synthomer’s future decisions and stakeholder interests.
Synthomer PLC announced that its Chief Financial Officer, Lily Liu, has opted to defer a portion of her 2024 annual cash bonus into shares of the company. This transaction, conducted on the London Stock Exchange, involves 54,990 ordinary shares at a price of £1.1784 each, totaling £64,800.22. This move reflects a strategic decision by the company’s management, potentially indicating confidence in the company’s future performance and aligning executive interests with shareholder value.
Synthomer PLC announced that its CEO, Michael Willome, has deferred part of his 2024 annual cash bonus into shares, purchasing 70,000 ordinary shares at a price of £1.184954 each, totaling £82,946.78. This transaction, conducted on the London Stock Exchange, reflects a strategic move that aligns the CEO’s interests with those of shareholders, potentially impacting the company’s market perception and stakeholder confidence.
Synthomer plc reported robust financial progress for the year ending December 2024, driven by strategic repositioning and self-help initiatives. The company achieved a 5.1% increase in revenue at constant currency, with significant improvements in EBITDA and underlying operating profit. Despite mixed end-market demand trends, Synthomer’s Adhesive Solutions and Health & Protection divisions showed strong performance, while Coatings & Construction Solutions faced challenges. The company maintained a stable financial position, completing a €350m bond refinancing and reducing its manufacturing sites. Looking ahead, Synthomer expects further financial progress in 2025 through continued strategic delivery and self-help actions.
Synthomer PLC has announced a change in its voting rights following an acquisition or disposal by Artemis Investment Management LLP. As of February 11, 2025, Artemis holds 5.034% of voting rights in Synthomer, highlighting a significant stake in the company. This change in holdings may impact Synthomer’s decision-making processes and potentially influence its strategic direction.